Butterfly Network, Inc.

NYSE:BFLY

Medical - Devices

Healthcare
$6.08 +32.84%

+$1.88 today

Market cap
$1.63B
Beta
2.20
P/E (TTM)
-25.7
EPS (TTM)
-$0.30
52W Low $1.32High $8.01

Volume 4.78M

Average 4.92M

BFLY Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Butterfly Network, Inc.NYSE: BFLY

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables growth accelerates

Q1 FY2026 accounts receivables of $1.41M rose 64.4% year over year, ahead of the -10.1% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at +30.2% a year.

Context

  • Accounts receivables amounted to 6.9% of revenue in FY2025, down 3.4 pp from a year earlier.
  • Accounts receivables grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +64.4% holds above the trailing-twelve-month pace of -10.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.41M+150.7% QoQ
Last fiscal yearDec 2025
-$6.75M-20.6% YoY
LTMMar 2026
-$6.2M-10.1% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+64.4%——
1 year-20.6%——
3-year CAGR+30.2%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(6.75M) USD
Year-over-year change
+20.6%

Accounts Receivables vs competitors

How BFLY compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -10.1% is the 7th highest of 9, against a peer median of +133.0%.
  • Accounts receivables amounts to 6.0% of revenue for BFLY, versus a peer median of 1.3%.
BFLY Competitors
Accounts Receivables for BFLY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EVHEvolent Health, Inc.LTM Mar 2026$85.22M USD+3185.5%—4.5%
AMNAMN Healthcare Services, Inc.LTM Mar 2026$41.69M USD-76.5%+55.1%1.2%
BFLYButterfly Network, Inc.LTM Mar 2026$6.2M USD-10.1%+30.2%6.0%
OFIXOrthofix Medical Inc.LTM Mar 2026$5.26M USD+166.0%-38.3%0.6%
SIBNSI-BONE, Inc.LTM Mar 2026$4.72M USD-7.3%-22.4%2.3%
FLGTFulgent Genetics, Inc.LTM Mar 2026$2.3M USD-89.7%—0.7%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$2.3M USD+273.6%—1.4%
ARVNArvinas, Inc.LTM Mar 2026$2M USD+253.8%-19.5%2.2%
VALNValneva SELTM Mar 2026€0 EUR+100.0%+2.4%0.0%
Peer median (excluding BFLY) —+133.0%-19.5%1.3%

Competitors are the stored peer set for BFLY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(32.41M)(168.72M)(133.7M)(72.49M)(77.06M)
Depreciation & Amortization2.09M5.94M10.57M10.34M8.08M
Deferred Income Tax00000
Stock-Based Compensation47.8M42.53M27.48M21.03M23.44M
Change in Working Capital(51.05M)(29.4M)(20.13M)(4.82M)15.24M
Accounts Receivables(6.13M)(3.06M)(162K)(8.5M)(6.75M)
Inventory(11.29M)(24.51M)(34.14M)2.22M1.43M
Accounts Payables(10.52M)1.22M(1.88M)(841K)5.09M
Other Working Capital(23.12M)(3.04M)16.04M2.31M15.47M
Other Non-Cash Items(155.62M)(19.46M)16.96M4.23M17.61M
Operating Cash Flow(189.19M)(169.12M)(98.82M)(41.71M)(12.7M)
Capital Expenditures(7.88M)(18.3M)(5.78M)(2.69M)(3.35M)
Acquisitions (Net)00000
Purchases of Investments(1.02B)(75.53M)(297K)00
Sales of Investments1.02B076.48M00
Other Investing Activities057K10K36K0
Investing Cash Flow(9.87M)(93.78M)70.41M(2.66M)(3.35M)
Debt Repayment(4.37M)0000
Common Stock Issued548.4M0002.23M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities21.66M2.88M228K(1.5M)75.53M
Financing Cash Flow565.69M2.88M228K(1.5M)77.76M
Effect of Forex Changes00000
Net Change in Cash366.64M(260.01M)(28.18M)(45.86M)61.71M
Free Cash Flow(197.06M)(187.42M)(104.6M)(44.4M)(16.05M)

Butterfly Network, Inc.

NYSE:BFLY

Intrinsic Alpha fair value

Locked

Current Price

$6.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.